Samsung Biologics
207940.KS
#478
Rank
C$70.18 B
Marketcap
C$1,447
Share price
-1.45%
Change (1 day)
23.79%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2026 (TTM): C$2.33 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are C$3.08 Billion. In 2025 the company made an earning of C$2.14 Billion, an increase over its 2024 earnings that were of C$1.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$2.33 B8.82%
2025 C$2.14 B45.86%
2024 C$1.47 B12.54%
2023 C$1.30 B9.73%
2022 C$1.19 B67.4%
2021 C$0.71 B104%
2020 C$0.34 B57.54%
2019 C$0.22 B-45.41%
2018 C$0.40 B-389.75%
2017 -C$0.15 Billion-46.69%
2016 -C$0.27 Billion